Related Experiment Video
Updated: Apr 9, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Pacemaker Lead-Associated Innominate Vein Thrombosis Despite Non-vitamin K Oral Anticoagulant (NOAC) Therapy: An
Neeraj Joshi1, Rachel Hallam2, Zaw Nyein Aye2
1Cardiology, East Kent Hospitals University NHS Foundation Trust, Queen Elizabeth The Queen Mother (QEQM) Hospital, Margate, GBR.
Abstract:
Venous thrombosis occurring despite therapeutic non-vitamin K oral anticoagulant (NOAC) therapy represents a diagnostic and management challenge, particularly in patients with indwelling cardiac implantable electronic devices. Pacemaker-associated central venous thrombosis is a recognized but often underdiagnosed finding due to its frequently asymptomatic presentation. We report the case of an older adult with a permanent pacemaker implanted approximately 10 months earlier who was undergoing evaluation for unexplained weight loss, in whom cross-sectional imaging incidentally revealed left innominate vein thrombosis without clinical features of venous obstruction. The patient was receiving full-dose NOAC therapy for atrial fibrillation, with good adherence and no alternative provoking factors identified. This case highlights the importance of recognizing venous thrombosis in patients with cardiac implantable electronic devices despite therapeutic anticoagulation and supports a careful, mechanism-based approach to evaluation and management in similar situations.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

